CORC

在结果中检索

CORC

浏览/检索结果: 共29条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology 期刊论文
CANCER BIOLOGY & MEDICINE, 2019, 卷号: 16, 期号: 1
作者:  Wu, Chunyan;  Shao, Zhimin;  Xu, Binghe;  Zhang, Qingyuan;  Xu, Ruihua
收藏  |  浏览/下载：123/0  |  提交时间：2019/12/05
Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial 期刊论文
EUROPEAN JOURNAL OF CANCER, 2019, 卷号: 112
作者:  Yuan, Peng;  Hu, Xichun;  Sun, Tao;  Li, Wei;  Zhang, Qingyuan
收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study 期刊论文
LANCET, 2019, 卷号: 394, 期号: 10196
作者:  Huang, Kewu;  Yang, Ting;  Xu, Jianying;  Yang, Lan;  Zhao, Jianping
收藏  |  浏览/下载：66/0  |  提交时间：2019/12/05
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2019, 卷号: 20, 期号: 6
作者:  Jiang, Zefei;  Li, Wei;  Hu, Xichun;  Zhang, Qingyuan;  Sun, Tao
收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study 会议论文
作者:  Xu, Rui-hua;  Wang, Fenghua;  Xu, Nong;  Shen, Lin;  Dai, Guanghai
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials 期刊论文
ONCOIMMUNOLOGY, 2018, 卷号: 7, 期号: 12
作者:  Huang, Qingyuan;  Zhang, Hua;  Hai, Josephine;  Socinski, Mark A.;  Lim, Eric
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study 会议论文
作者:  Xu, Rui-hua;  Wang, Fenghua;  Shi, Jianhua;  Feng, Ji Feng;  Shen, Lin
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study 期刊论文
LANCET, 2018, 卷号: 391, 期号: 10131
作者:  Wang, Chen;  Xu, Jianying;  Yang, Lan;  Xu, Yongjian;  Zhang, Xiangyan
收藏  |  浏览/下载：41/0  |  提交时间：2019/12/05
Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy 期刊论文
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 卷号: 144, 期号: 6
作者:  Wang, Yiyang;  Zheng, Difan;  Zheng, Jiajie;  Huang, Qingyuan;  Han, Baohui
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Recombinant humanised anti-PD-1 monoclonal antibody (JS001) treatment for patients with refractory or metastatic nasopharyngeal carcinoma: preliminary results of an open-label, phase 1b/2, clinical study 会议论文
作者:  Xu, Ruihua;  Wang, Fenghua;  Li, Qi;  Shi, Jianhua;  Shen, Lin
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace